Is Collplant Biotechnologies Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: CLGN) stock is to Strong Buy CLGN stock.
Out of 2 analysts, 1 (50%) are recommending CLGN as a Strong Buy, 1 (50%) are recommending CLGN as a Buy, 0 (0%) are recommending CLGN as a Hold, 0 (0%) are recommending CLGN as a Sell, and 0 (0%) are recommending CLGN as a Strong Sell.
What is CLGN's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: CLGN) forecast ROE is N/A, which is considered weak.
What is CLGN's Price Target?
According to 2 Wall Street analysts that have issued a 1 year CLGN price target, the average CLGN price target is $16.88, with the highest CLGN stock price forecast at $22.75 and the lowest CLGN stock price forecast at $11.00.
On average, Wall Street analysts predict that Collplant Biotechnologies's share price could reach $16.88 by Mar 30, 2024. The average Collplant Biotechnologies stock price prediction forecasts a potential upside of 121.17% from the current CLGN share price of $7.63.
What is CLGN's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: CLGN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.1%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.